Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert J Hamilton

Showing results (91-100 of 279) with videos related to

Pageof 28
Sort By:
Clinical Genitourinary Cancer|July 18, 2016
Metformin Use and Kidney Cancer Outcomes in Patients With Diabetes: A Propensity Score AnalysisMadhur Nayan, Antonio Finelli, Michael A S Jewett, et al.
Prostate Cancer and Prostatic Diseases|April 8, 2025
The association between statin use, genetic variation, and prostate cancer riskAli Amiri, Wei Xu, Qihuang Zhang, et al.
The Journal of Urology|January 22, 2008
Seminal plasma lipocalin-type prostaglandin D synthase: a potential new marker for the diagnosis of obstructive azoospermiaSamy M Heshmat, J Brendan Mullen, Keith A Jarvi, et al.
Urologic Oncology|July 12, 2021
Applicant perceptions of virtual interviews for society of urologic oncology fellowships during the COVID-19 pandemicJohn L Gore, Sima P Porten, Jeffrey S Montgomery, et al.
Urologic Oncology|February 14, 2017
Effect of statins as a secondary chemopreventive agent among individuals with non-muscle-invasive bladder cancer: A population-based analysisPatrick O Richard, Ardalan E Ahmad, Shaheena Bashir, et al.
The Journal of Urology|March 18, 2008
Limitations of prostate specific antigen doubling time following biochemical recurrence after radical prostatectomy: results from the SEARCH databaseRobert J Hamilton, William J Aronson, Martha K Terris, et al.
European Urology|April 2, 2013
Obesity is associated with increased prostate growth and attenuated prostate volume reduction by dutasterideRoberto L Muller, Leah Gerber, Daniel M Moreira, et al.
Cancer|September 19, 2007
Race, biochemical disease recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH databaseRobert J Hamilton, William J Aronson, Joseph C Presti, et al.
The Journal of Urology|December 3, 2013
The association between statin medication and progression after surgery for localized renal cell carcinomaRobert J Hamilton, Daniel Morilla, Fernando Cabrera, et al.
Urology|September 2, 2024
Statin Concentration in Prostatic Tissue is Subtype- and Dose-dependentJulian Chavarriaga, Linda Z Penn, Najia Khurram, et al.
Pageof 28

Showing results (91-100 of 279) with videos related to

Sort By:
Pageof 28
Clinical Genitourinary Cancer|July 18, 2016
Metformin Use and Kidney Cancer Outcomes in Patients With Diabetes: A Propensity Score AnalysisMadhur Nayan, Antonio Finelli, Michael A S Jewett, et al.
Prostate Cancer and Prostatic Diseases|April 8, 2025
The association between statin use, genetic variation, and prostate cancer riskAli Amiri, Wei Xu, Qihuang Zhang, et al.
The Journal of Urology|January 22, 2008
Seminal plasma lipocalin-type prostaglandin D synthase: a potential new marker for the diagnosis of obstructive azoospermiaSamy M Heshmat, J Brendan Mullen, Keith A Jarvi, et al.
Urologic Oncology|July 12, 2021
Applicant perceptions of virtual interviews for society of urologic oncology fellowships during the COVID-19 pandemicJohn L Gore, Sima P Porten, Jeffrey S Montgomery, et al.
Urologic Oncology|February 14, 2017
Effect of statins as a secondary chemopreventive agent among individuals with non-muscle-invasive bladder cancer: A population-based analysisPatrick O Richard, Ardalan E Ahmad, Shaheena Bashir, et al.
The Journal of Urology|March 18, 2008
Limitations of prostate specific antigen doubling time following biochemical recurrence after radical prostatectomy: results from the SEARCH databaseRobert J Hamilton, William J Aronson, Martha K Terris, et al.
European Urology|April 2, 2013
Obesity is associated with increased prostate growth and attenuated prostate volume reduction by dutasterideRoberto L Muller, Leah Gerber, Daniel M Moreira, et al.
Cancer|September 19, 2007
Race, biochemical disease recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH databaseRobert J Hamilton, William J Aronson, Joseph C Presti, et al.
The Journal of Urology|December 3, 2013
The association between statin medication and progression after surgery for localized renal cell carcinomaRobert J Hamilton, Daniel Morilla, Fernando Cabrera, et al.
Urology|September 2, 2024
Statin Concentration in Prostatic Tissue is Subtype- and Dose-dependentJulian Chavarriaga, Linda Z Penn, Najia Khurram, et al.
Pageof 28